Nanopath
company
About
Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $10M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2019
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$10.25M
Nanopath has raised a total of
$10.25M
in funding over 2 rounds. Their latest funding was raised on
Aug 9, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 9, 2022 | Series A | $10M | 1 |
Norwest Venture Partners
|
— | Detail |
| Dec 21, 2021 | Grant | $255.87K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
Nanopath is funded by 2 investors.
Norwest Venture Partners
and National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Norwest Venture Partners
|
Yes | Series A |
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
